Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Investors with an eye on the biotechnology sector may want to pay close attention to Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage company making waves with its innovative approach to protein..
Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering force in the healthcare sector, is capturing investor attention with its focus on innovative treatments for liver cancers. Headquartered in New York, this..
Prothena Corporation plc (NASDAQ: PRTA), a dynamic player in the biotechnology sector, offers a compelling case for investors seeking exposure to innovative healthcare solutions. Based in Dublin, Ireland, Prothena is..
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating brain health disorders. Based in New York,..
Investors with an eye on the biotechnology sector may find Inventiva S.A. – American Depositary Shares (IVA) an intriguing prospect. With a reported potential upside of 122.69%, this French biopharmaceutical..
OrthoPediatrics Corp. (NASDAQ: KIDS), a specialized player in the healthcare sector, focuses on the niche yet crucial segment of pediatric orthopedic medical devices. Headquartered in Warsaw, Indiana, this innovative company..
Maze Therapeutics, Inc. (MAZE) is a clinical-stage biopharmaceutical company operating in the dynamic biotechnology sector. With a market capitalization of $1.16 billion, this South San Francisco-based firm is making waves..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) presents a compelling narrative for investors within the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in South San Francisco, California, focuses on developing therapies to..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a standout player in the biotechnology sector, is piquing investor interest with its compelling growth narrative and promising market outlook. Headquartered in South San Francisco,..
AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology company headquartered in Vancouver, is capturing the attention of investors with its promising growth metrics and substantial potential upside. Despite the challenges..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a name that investors in the biotechnology sector should keep an eye on, especially those interested in the cutting-edge field of gene therapy. With..
Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands as a compelling opportunity in the biotechnology sector, offering a fascinating proposition for investors who are keen on the healthcare landscape. With its focus..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands as a notable player within the healthcare sector, specifically focusing on the medical devices industry in the United States. With a market capitalization..
AngioDynamics, Inc. (ANGO), a prominent player in the medical technology landscape, is capturing investor attention with a robust revenue growth of 12.90% and an enticing potential upside of 55.45%. With..
For investors with a keen eye on the biotechnology sector, Autolus Therapeutics plc (NASDAQ: AUTL) presents an intriguing opportunity. With a potential upside of nearly 497.65%, this London-based clinical-stage biopharmaceutical..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a prominent player in the biotechnology space, has been capturing investor attention with its innovative approach to treating serious retinal diseases. With a current market..
Humacyte, Inc. (NASDAQ: HUMA) is making waves in the biotechnology sector with its revolutionary approach to developing off-the-shelf, implantable, and bioengineered human tissues. With a market capitalization of $284.32 million,..
Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the healthcare sector, specializes in regenerative medicine, offering advanced wound care, surgical, and sports medicine solutions. Despite its recent challenges, the..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to cancer treatment. With a market capitalization of $2.1 billion,..
As investors navigate the intricate world of biotechnology stocks, GH Research PLC (NASDAQ: GHRS) stands out as a company with significant growth potential. Based in Dublin, Ireland, GH Research is..
